| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2006;114:2280-2287.)
© 2006 American Heart Association, Inc.
Transplantation |
From the Division of Cardiothoracic Surgery, Department of Surgery (M.J.R., J.M.C., K.N.H., A.S.S., M.A., M.C.O., Y.N.) and Division of Cardiology, Department of Medicine (D.D.A., D.M.M.), College of Physicians and Surgeons, and the International Center for Health Outcomes and Innovation Research (InCHOIR; M.J.R., D.D.A.); Columbia University New York, NY.
Correspondence to Yoshifumi Naka, MD, PhD, New York-Presbyterian Hospital/Columbia, Milstein Hospital Bldg, Room 7-435 GN, 177 Fort Washington Ave, New York, NY 10032. E-mail yn33{at}columbia.edu
Received January 23, 2006; revision received July 28, 2006; accepted August 22, 2006.
Background This study compares posttransplantation outcomes of survival and morbidity among recipients with and without diabetes mellitus (DM).
Methods and Results The United Network of Organ Sharing (UNOS) provided deidentified patient-level data. Primary analysis focused on 20 412 first-time heart transplant recipients aged
18 years who underwent transplantation between January 1, 1995, and December 31, 2005. To determine severity of DM, DM recipients were stratified by their aggregate number of diabetes-related complications (DRCs), including pretransplantation history of renal failure (serum creatinine=2.5 mg/dL), peripheral vascular disease, cerebrovascular accident, and severe obesity (body mass index
35 kg/m2). Kaplan-Meier analysis was performed to compare time to event. Although posttransplantation survival was significantly better (P<0.001) among patients without DM (median survival 10.1 years) than among those with DM (9.0 years), survival did not differ (P=0.08) between those without DM (10.1 years) and those with uncomplicated DM (0 DRCs; 9.3 years). Among those with DM, survival was worse with each additional DRC: 0 DRC, 9.3 years; 1 DRC, 6.7 years; and
2 DRCs, 3.6 years. Although acute rejection and transplant coronary artery diseasefree survival did not differ between groups, renal failure and severe infection-free survival were worse in those with DM and were inversely related to the number of DRCs.
Conclusions Posttransplantation survival among patients with uncomplicated DM was not significantly different than that among nondiabetics. However, when stratified by disease severity, recipients with more severe diabetes had significantly worse survival than nondiabetics. Therefore, although DM alone should not be a contraindication to heart transplantation, given the critical shortage of transplantable organs, maximal benefit may be achieved by exploring alternative treatment options in patients with severe DM. These include use of high-risk transplant lists and destination therapy.
This article has been cited by other articles:
![]() |
L. Miller Heart Transplantation in Patients With Diabetes Circulation, November 21, 2006; 114(21): 2206 - 2207. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |